Edition:
India

Five Prime Reports Q4 Loss Per Share $1.04


Wednesday, 28 Feb 2018 

Feb 27 (Reuters) - Five Prime Therapeutics Inc ::FIVE PRIME ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $1.04.FIVE PRIME THERAPEUTICS - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED $292.7 MILLION ON DEC 31, 2017 VERSUS $421.7 MILLION ON DECEMBER 31, 2016. 

Company Quote

5.17
-0.06 -1.15%
23 Sep 2019